Primary Empty Sella Syndrome and the Prevalence of Hormonal Dysregulation
- PMID: 29510819
- PMCID: PMC5842341
- DOI: 10.3238/arztebl.2018.0099
Primary Empty Sella Syndrome and the Prevalence of Hormonal Dysregulation
Abstract
Background: Empty sella is the neuroradiological or pathological finding of an apparently empty sella turcica containing no pituitary tissue. The prevalence of primary empty sella, i.e., empty sella without any discernible cause, is not precisely known; estimates range from 2% to 20%. Technical advances in neuroradiology have made empty sella an increasingly common incidental finding. It remains unclear whether, and to what extent, asymptomatic adult patients with an incidentally discovered empty sella should undergo diagnostic testing for hormonal disturbances.
Methods: To answer this question, the authors carried out a systematic search in the PubMed and Web of Science databases for publications that appeared in the period 1995-2016 and that contained the search term "empty sella" (registration: PROSPERO 2015: CRD42015024550).
Results: The search yielded 1282 hits. After the exclusion of duplicates, pediatric reports, case reports, and veterinary studies, 120 publications on primary empty sella syndrome (PES) were identified. 4 of these dealt with the prevalence of pituitary insufficiency in patients with PES as an incidental finding. Among patients with PES, the relative frequency of pituitary insufficiency in the pooled analysis was 52% (95% confidence interval [38; 65]).
Conclusion: The data on PES as an incidental finding are too sparse to enable any evidence-based recommendation on the potential indications for hormone testing or its nature and extent. We advise basic neuroendocrinological testing (fasting cortisol, free thyroxine [fT4], estradiol or testosterone, insulin-like growth factor 1 [IGF-1], and prolactin). There is an unexplained discrepancy between the reported high prevalence of pituitary insufficiency among persons with PES and its low prevalence in epidemiologic studies. We suspect that the former may be high because of selection bias in the publications that we reviewed, or else the latter may be erroneously low.
Figures



Comment in
-
Rainbow Cup.Dtsch Arztebl Int. 2018 May 4;115(18):324. doi: 10.3238/arztebl.2018.0324a. Dtsch Arztebl Int. 2018. PMID: 29807562 Free PMC article. No abstract available.
-
Not an "All-or-Nothing" Principle.Dtsch Arztebl Int. 2018 May 4;115(18):324. doi: 10.3238/arztebl.2018.0324b. Dtsch Arztebl Int. 2018. PMID: 29807563 Free PMC article. No abstract available.
-
Overdiagnosis is Stressful.Dtsch Arztebl Int. 2018 May 4;115(18):324-325. doi: 10.3238/arztebl.2018.0324c. Dtsch Arztebl Int. 2018. PMID: 29807564 Free PMC article. No abstract available.
References
-
- Webb SM, Crespo I, Santos A, Resmini E, Aulinas A, Valassi E. Management of endocrine disease: quality of life tools for the management of pituitary disease. Eur J Endocrinol. 2017;177:R13–R26. - PubMed
-
- Giavoli C, Profka E, Verrua E, et al. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency. J Clin Endocrinol Metab. 2012;97:3983–3988. - PubMed
-
- Busch W. Morphology of sella turcica and its relation to the pituitary gland. Virchows Arch. 1951;320:437–458. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous